Luciferase Assay Negative Control

Human Hantavirus Nucleoprotein (HVNP) IgG negative control serum
AE-310620-NC 1 ml
EUR 196.8

Human IgG antibody Laboratories manufactures the luciferase assay negative control reagents distributed by Genprice. The Luciferase Assay Negative Control reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact luciferase assay. Other Luciferase products are available in stock. Specificity: Luciferase Category: Assay Group: Negative Control

Chicken Anti-Toxoplasma gondii IgG negative control serum
1 ml
EUR 196.8

Baboon Anti-Rabies Virus IgG antiserum negative control
1 ml
EUR 196.8

Kemptide Negative Control Peptide
  • EUR 427.20
  • EUR 644.40
  • EUR 343.20
  • 10 mg
  • 25 mg
  • 5 mg

QVD-OPh Negative Control
each
EUR 248.4

QVD-OPh Negative Control
each
EUR 483.6

QVD-OPh Negative Control
each
EUR 705.6

Negative Control Luciferase Lentivirus
500 µl x 2
EUR 860
Description: The Negative Control Lentivirus (Firefly Luciferase) are replication incompetent, HIV-based, VSV-G pseudo typed lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The particles contain a firefly luciferase gene under the control of a minimal TATA promoter, without any additional transcriptional response elements.

Negative Control information

pGreenZeo-mCMV Plasmid [negative control]
SR500PA-1 10 ug
EUR 474

NATtrol BV Negative Control (6 X 0.15mL)
NATBVNEG-BD 6 X 0.15mL
EUR 295

EZSolution? Q-VD-OPh, Negative Control
1174-1 each
EUR 248.4

Expression Negative Control Lentivirus (G418)
79902-G 500 µl x 2
EUR 795
Description: The Expression Negative Control Lentivirus are replication incompetent, HIV-based, VSV-G pseudotyped lentiviral particles that are ready to be transduced into almost all types of mammalian cells, including primary and non-dividing cells. The controls package the same virus particles as the target expression virus, but they do not express a specific protein under the CMV promoter. _x000D_The Expression Negative Control Lentivirus (G418) expresses the gene for aminoglycoside 3' phosphotransferase, which confers resistance to kanamycin, neomycin, and geneticin (G418)._x000D_The Expression Negative Control Lentivirus (Hygromycin) expresses the gene for hygromycin B phosphotransferase, which confers resistance to Hygromycin._x000D_The Expression Negative Control Lentivirus (Puromycin) expresses the gene for puromycin N-acetyl-transferase, which confers resistance to puromycin._x000D_ _x000D_

ODN 2006-Type B (human, Negative Control)
VAdv-Ly0070 5 mg
EUR 4332
Description: ODN 2006-Type B, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 2216-Type A (human, Negative Control)
VAdv-Ly0075-1mg 1 mg
EUR 1528.8
Description: ODN 2216-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 2216-Type A (human, Negative Control)
VAdv-Ly0075-5mg 5 mg
EUR 4332
Description: ODN 2216-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 2336-Type A (human, Negative Control)
VAdv-Ly0077-1mg 1 mg
EUR 1528.8
Description: ODN 2336-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 2336-Type A (human, Negative Control)
VAdv-Ly0077-5mg 5 mg
EUR 4332
Description: ODN 2336-Type A, human TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

NATtrol Norovirus Negative Control (6 x 0.125mL)
NATROTA-6MC 6 x 0.125mL
EUR 203

ODN 1668-Type B (murine, Negative Control)
VAdv-Ly0071-1mg 1 mg
EUR 1528.8
Description: ODN 1668-Type B, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 1668-Type B (murine, Negative Control)
VAdv-Ly0071-5mg 5 mg
EUR 4332
Description: ODN 1668-Type B, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 2088-Type A (murine, Negative Control)
VAdv-Ly0072-1mg 1 mg
EUR 1528.8
Description: ODN 2088-Type A, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 2088-Type A (murine, Negative Control)
VAdv-Ly0072-5mg 5 mg
EUR 4332
Description: ODN 2088-Type A, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

ODN 1826-Type B (murine, Negative Control)
VAdv-Ly0074 5 mg
EUR 4332
Description: ODN 1826-Type B, murine TLR9 agonist, oligodeoxy nucleotide vaccine adjuvant.

NATtrol EV Negative Control (6 X 0.2 mL)
NATEVNEG-6MC 6 X 0.2 mL
EUR 208

NATtrol EV Negative Control (6 X 0.5 mL)
MDZ056 6 X 0.2 mL
EUR 208